Search
Search Results
##search.searchResults.foundPlural##
-
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3424PDF: 2332HTML: 1411 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1857PDF: 831HTML: 1251 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1906PDF: 1347HTML: 246 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1502PDF: 853HTML: 964figures: 150table 1: 162table2: 160table3: 161 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7194PDF: 2368HTML: 1703Table 1.: 183Table 2.: 199Table 3.: 179Table 4.: 178 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2516PDF: 1568HTML: 2334Table1: 172 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1437PDF: 353HTML: 182 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1060PDF: 459HTML: 211 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1351PDF: 718HTML: 191 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1523PDF: 547HTML: 213 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1233PDF: 770HTML: 113 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2016PDF: 962HTML: 4050Cover Letter: 205Figure 1: 202Figure 2: 211Table 1: 187 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3992PDF: 1534HTML: 834 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1335PDF: 795HTML: 3103 -
Skin Involvement in Primary Systemic Amyloidosis
1540PDF: 861HTML: 4345Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 158Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 116Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 157 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1763PDF: 688HTML: 2082Untitled: 192Untitled: 139Untitled: 151Untitled: 140Untitled: 145Untitled: 161Untitled: 167 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3904PDF: 1266HTML: 2241 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1406PDF: 512HTML: 655 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1200PDF: 450HTML: 18541Figure 1: 151Figure 2: 137Figure 3: 153Figure 4: 185Figure 5: 156 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2075PDF: 1926HTML: 143 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
780PDF: 774HTML: 95 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1103PDF: 457HTML: 195 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1133PDF: 721HTML: 1330Figure 1: 157Figure 2: 155 -
-
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1688PDF: 848HTML: 359Fig1: 211Fig.2: 228Fig. 3: 159Fig. 5: 167Fig. 4: 196 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3249PDF: 688HTML: 700Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 163Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 159Table : Distribution of the sites of bleeding and their causes: 163







